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Interleukin-10(IL-10)playsanindispensableroleinmucosaltolerancebyprogrammingdendriticcells(DCs)toinducesuppressor
Th-cells.WehavetestedthemodulatingeﬀectofL.lactissecretinghumanIL-10(L. lactisIL-10)onDCfunctioninvitro.Monocyte-
derivedDCincubatedwithL. lactisIL-10 inducedeﬀectorTh-cellsthatmarkedlysuppressedtheproliferationofallogenicTh-cellsas
compared to L. lactis. This suppressive eﬀect was only seen when DC showed increased CD83 and CD86 expression. Furthermore,
enhanced production of IL-10 was measured in both L. lactisIL-10-derived DC and Th-cells compared to L. lactis-derived DC and
Th-cells.NeutralizingIL-10duringDC-Th-cellinteractionandcoculturingL. lactisIL-10-derivedsuppressorTh-cellswithallogenic
Th-cells in a transwell system prevented the induction of suppressor Th-cells. Only 130pg/mL of bacterial-derived IL-10 and 40
times more exogenously added recombinant human IL-10 were needed during DC priming for the generation of suppressor Th-
cells. The spatially restricted delivery of IL-10 by food-grade bacteria is a promising strategy to induce suppressor Th-cells in vivo
and to treat inﬂammatory diseases.
1.Introduction
The gastrointestinal mucosal immune system is continu-
ously balancing between tolerance towards nonpathogenic
bacteria and active immunity toward pathogenic bacteria
[1]. Animal models have clearly shown that IL-10 is an
important regulator in this context as IL-10 knock-out
mice develop chronic intestinal inﬂammation and IL-10
treatment is eﬀective in several models of experimental
colitis [2–4]. Unfortunately, several clinical attempts to treat
inﬂammatory bowel disease using IL-10 have failed probably
due to low mucosal availability and proinﬂammatory eﬀects
of high-dose systemic IL-10 administration [5–8]. The pro-
duction of human IL-10 by Lactococcus lactis (L. lactisIL-10)
could circumvent these problems. Indeed, L. lactisIL-10 is
eﬀectiveinthepreventionandtreatmentofcolitisinanimals,
and a phase-I clinical trial with L. lactisIL-10 in Crohn’s
disease patients suggested clinical beneﬁt [9]. Dendritic
cells (DC) are regulators of the adaptive immune system
controllingbothperipheraltoleranceandimmuneactivation
[10]. In the absence of pathogenic microorganisms, DC
are tuned by microenvironmental factors to induce and
maintain tolerance in the intestinal tract. This homeostatic
condition is critically controlled by cytokines including
IL-10 [11]. Culturing immature DC with IL-10 results
in Th-cell responses which suppress the proliferation of
allogenic Th-cells in a contact-dependent manner which is
not dependent on IL-10 production by (suppressor) Th-cells
[12]. We hypothesized that L. lactisIL-10 is able to modulate
immatureDCtobecomeregulatoryDCwhichinturninduce
suppressor T cells.2 Gastroenterology Research and Practice
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Figure 1: (a) Immature DC were matured with no bacteria, 1 × 105 cfu of viable L. lactisIL-10 or L. lactis in the presence of MF. Mature
DC were subsequently cultured with na¨ ıve Th-cells to induce eﬀector Th-cells which were harvested, washed, and stained with 3 × 10−5 M
PKH-26, a red cell-cycle tracking dye. Then, 2.5 × 104 eﬀector Th-cells were preactivated overnight with anti-CD3 (1:5000) and anti-
CD28 (0.5mg/mL) in round-bottom 96-well plates. The following day allogenic (CD4+) Th-cells were labeled with CFSE, a green cell-cycle
trackingdye.After5days,thecellularcontentofCFSEintheallogenicTh-cellswasanalyzedbyﬂowcytometry[13].Depictedisthecellcycle
progression of allogenic Th-cells stimulated in the presence of MF derived eﬀector Th-cells (white histograms, reference condition) and of
allogenic Th-cells cultured in the presence of MF/L. lactisIL-10 or MF/L. lactis derived eﬀector Th-cells (gray histograms). (b) Depicted is the
mean inhibition of ﬂuorescence intensity of allogenic Th-cells from ﬁve separate experiments for the indicated conditions. The proliferation
of allogenic Th-cells cultured in the presence of eﬀector Th-cells derived from MF-matured DC which is regarded as 100% (reference
condition). Mean percentages with standard error of mean are given; ∗indicates P<0.05 and ∗∗indicates P<0.01 using the χ2-test for
comparing percentages with the reference condition (MF).
2.MaterialsandMethods
2.1. Bacterial Strains. For the generation of Lactococcus lactis
MG1363 IL-10 (L. lactisIL-10)a n dLactococcus lactis MG1363
(L. lactis), the plasmid pOTHY12 was used (Lothar Steidler,
ActoGeniX, Belgium). The plasmid contains a 1Kb region
including the constitutive thyA promoter (PthyA)f r o mL .
lactis MG1363, the usp45 secretion leader, hIL-10, and a
1Kb region downstream of thyA gene. This leads to a
functional coupling of PthyA to usp45-hIL-10, expression
of the precursor, correct N-terminal processing of the
precursor, and secretion of mature hIL-10. In optimized in
vitro growth, L. lactis MG1363 pOTHY12 will produce in its
culture supernatant approximately 1μg hIL-10 per 2 × 109
bacteria.Forthegenerationofthenegativecontrol(L.lactis),
L. lactis MG1363 was transformed with an empty plasmid.
Both L. lactisIL-10 and L. lactis were grown overnight at 37◦C
(Elbanton incubator) in M17 broth (Difco) supplemented
with 0.5% glucose and 50μg/mL erythromycin (Abbott,
Saint-R´ emy-sur-Avre, France). Bacteria were diluted 1:50
in IMDM 5% FCS, grown for three hours at 37◦C, and
harvested at exponential growth phase (approximately 1 ×
107 cfu/mL).
2.2. Generation and Maturation of DC. A l lc u l t u r e sw e r e
performedinIscove’smodiﬁedDulbecco’smedium(IMDM)
with 1% FCS (HyClone, Logan, UT) and erythromycin
(50mg/mL, Abbott). Peripheral blood of healthy volunteers
was used to generate immature DC as earlier described [14].
Maturation was achieved at day 6 by adding 1 × 105 cfu bac-
teria with or without maturation factors (MF), recombinant
human (rh)-IL-1β (5ng/mL; Boehringer Mannheim, Ger-
many), rh-TNF-α (25ng/mL; PBH, Hannover, Germany),
and LPS (Sigma). After 4 hours, 50mL of supernatant was
harvested for measurement of bacterial IL-10 (ELISA; CLB,
Amsterdam, The Netherlands) and gentamycin (86μg/mL,
Sigma) was added to kill all bacteria. On day eight, mature
DCs were harvested and washed, and cultures of DC on M17
agars conﬁrmed that bacterial killing was complete. Mature
DCs were used for ﬂow cytometry to assess maturation
by CD83 and CD86 expression or stimulated with one
of the following stimuli: IFN-γ (gift from Dr. P van
der Meide; U-Cy tech, Utrecht, The Netherlands) and/or
CD40L-transfected J558 plasmacytoma cells (gift from Dr. P.
Lane, Birmingham Medical School, Birmingham, UK). After
48 hours, supernatants were used for cytokine detection
using ELISA for IL12p70 (R&D Systems, detection limit
31.2pg/mL) and IL-10 (CLB, detection limit 31.2pg/mL).
2.3. T-Cell Instruction by Mature DC. Mature DC (5 ×
103 cells/200μL) were incubated with 2.5 × 104 puriﬁed
CD4+CD45RA+CD45RO− na¨ ıve T cells (>90% as assessed
by ﬂow cytometry) from PBMC using MACS separation
system (Miltenyi Biotec, Germany). When indicated rat-
antihuman IL-10 neutralizing IgG1 (1:1000, BD Pharmin-
gen, San Jose, Calif, USA) antibodies were added, puriﬁed
rat IgG1 (BD Pharmingen) was used as isotype control.
Th-cells were further expanded and stimulated with solu-
ble mouse antihuman-CD3 and mouse antihuman-CD28
(both CLB). After 48 hours, supernatants were used for
cytokine detection using ELISA for IFN-γ (R&D Systems,
detection limit 31.2pg/mL) and IL-10 (CLB). Moreover,
expanded Th-cells were used in a Th-cell coculture model
to assess suppressor function of DC-derived Th-cells [15].
In short, expanded (eﬀector) Th-cells were cultured with
CD4+ (autologous) T cells and T-cell proliferation was
measured using cell-cycle tracking dyes; cell division results
in decreased ﬂuorescence intensity of separate cells. The
ﬂuorescence intensity of allogenic T cells, after culture withGastroenterology Research and Practice 3
E
v
e
n
t
CD83
30
0
0 102 104
CD86
E
v
e
n
t
30
0
0 102 104
(a)
Cell cycle
0 101 102 103 104
E
v
e
n
t
E
v
e
n
t
Cell cycle
0 101 102 103 104
L. lactisIL-10 L. lactis / MF IL-10
(b)
Figure 2: (a) Immature DCs were not matured (grey histogram), matured with 1 × 105 cfu viable L. lactisIL-10 (continuous line), or matured
with MF and 1 × 105 cfu viable L. lactisIL-10 (dotted line). CD83 (left panel) and CD86 (right panel) expression was assessed after 48 hours
b yﬂ o wc yt o m etry .( b )I m m a t u r eDC sw e r ep ri m e dwi t hM Fo r1× 105 cfu viable L. lactisIL-10 with and without MF. Depicted is the cell cycle
progression of allogenic Th-cells co-cultured with eﬀector Th-cells derived from MF-matured DC is regarded as 100% (white histograms,
reference condition) and the cell cycle progression of allogenic Th-cells cocultured with eﬀe c t o rT h - c e l l sd e r i v e df r o mL. lactisIL-10 (left
panel) or L. lactisIL-10 /MF-(right panel) matured DC (gray histograms).
eﬀector T cells derived from MF-matured DC, was taken as
100% (reference condition).
2.4.Statistics. Forcomparisonofcytokineproduction,ahet-
eroscedasticStudentt-testwasperformed,whileforcompar-
ison of percentages, a X2-test for comparing percentages was
performed. When multiple groups were present a Kruskall-
Wallis One-Way Analysis of Variance was performed (SPSS,
version 11.01, Chicago, Ill, USA). Statistical signiﬁcance was
deﬁned as a P<0.05, conﬁdence interval 95%.
3. Results
3.1. L. lactis(IL-10) M a t u r e sD Ct oP r o m o t et h eD e v e l o p m e n t
of Suppressor T Cells. DCs were matured in presence of
MF or MF with bacteria (L. lactis or L. lactisIL-10)a n d
used to diﬀerentiate na¨ ıve Th-cells into eﬀector Th-cells.
Subsequently, the generated eﬀector Th-cells were analyzed
for their eﬀect on Th-cell proliferation in a coculture model
[15]. The ﬂuorescence intensity of allogenic Th-cells after
culture with eﬀector Th-cells derived from MF-matured DC
was taken as 100% (reference condition). Eﬀector Th-cells
generated by MF/L. lactis-DC allowed the proliferation of
67% of all allogenic Th-cells (Figure 1(a)), while eﬀector
Th-cells generated by MF/L. lactisIL-10 -DC only allowed
proliferation of 42% of all allogenic Th-cells (Figure 1(a)).
T h em e a np r o l i f e r a t i o nf r o mﬁ v es e p a r a t ee x p e r i m e n t sw a s
72% (P<0.05) and 42% (P<0.01) for L. lactis and L.
lactisIL-10, respectively, indicating that IL-10 production by
L. lactis signiﬁcantly improved the suppression of allogenic
Th-cells proliferation by eﬀector Th-cells (Figure 1(b)).
3.2. The Induction of Suppressor Th-Cells by L.
lactis IL-10 Matured DC Is Dependent on Full Maturation of
DC. DC matured with L. lactisIL-10 in the absence of MF
showed a minimal increase in the expression of CD83 and4 Gastroenterology Research and Practice
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Figure 3 :( a )I m m a t u r eD C sw e r en o tm a t u r e d ,m a t u r e dw i t hM Fo rw i t h1× 105 cfu of viable L. lactis, L. lactisIL-10, L. lactisIL-10 /α-IL-10,
or L. lactisIL-10 /rat IgG1 in the presence of MF. Mature DCs were harvested after 48 hours, washed, and restimulated (2 × 104 cells in 200μL)
for 48 hours with CD40L transfected irradiated hybridoma cells to assess IL-10 production or in combination with IFN-γ to asses IL-12p70
production. Mean values with standard error of mean are given; ∗ indicates P<0.05 and ∗∗indicates P<0.01 using heteroscedastic Student
t-test. (b) Immature DCs were not matured, matured with MF or with 1 × 105 CFU of viable L. lactis, L. lactisIL-10, L. lactisIL-10 /α-IL-10 or L.
lactisIL-10 /rat IgG1 in the presence of MF. Mature DCs were subsequently cultured with na¨ ıve Th-cells for 5 days, these DC derived Th-cells
were washed and restimulated with CD3/CD28 (100.000cell/200μL, ﬁnal concentration 1:1000) to assess IL-10 and IFN-γ production.
Mean values with standard error of mean are given; ∗∗indicates P<0.01 using heteroscedastic Student t-test.
CD86 as expressed by mean ﬂuorescence intensity. When
MFs were added during maturation with L. lactisIL-10 a
strong upregulation of CD83 and CD86 was observed as
can be seen in the histograms (Figure 2(a)). Compared
to the reference condition, DC matured in the absence of
MF but in the presence of L. lactisIL-10 -induced eﬀector
Th-cells that were not able to signiﬁcantly suppress naive
T-cell proliferation. On the contrary when MF was added
together with L. lactisIL-10 during DC maturation, these
D C sw e r ea b l et oi n d u c ee ﬀector Th-cells that eﬃciently
reduced the proliferation of na¨ ıve T cells. Hence, lower
expression of CD83 and CD86 in L. lactisIL-10 matured DC
was associated with a marked reduction in their ability to
induce eﬀector Th-cells with suppressive eﬀects on allogenic
Th-cell proliferation (Figure 2(b)).
3.3. L. lactis IL-10 Matures DC to Produce IL-10 and Induces
IL-10 Producing Th-Cells. L. lactisIL-10 and L. lactis,i nc o m -
bination with MF, were used to mature DC. After 4 hours,
bacteria were killed with antibiotics, and after 48 hours,
matureDCswererestimulatedwithCD40L orCD40L/IFN-γ
to assess IL-10, IL-12p70, and IL-6 production, respectively.
DC produced 3200pg/mL and 1600pg/mL IL-10 after
maturation with L. lactisIL-10 and L. lactis, respectively, (P<
0.05, compared to L. lactis, Figure 3(a)). The production of
IL-12p70 (Figure 3(a)) and IL-6 (data not shown) was not
signiﬁcantly diﬀerent between the groups. Furthermore, IL-
10 and IFN-γ production by eﬀectorTh-cells,induced by the
diﬀerent DC groups, was measured. Maturation of DC with
L. lactisIL-10 or L. lactis in combination with MF resulted in
the induction of eﬀector Th-cells that produced 2400pg/mLGastroenterology Research and Practice 5
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Figure 4: (a) Depicted is the cell cycle progression of allogenic Th-cells cocultured with MF-derived eﬀector Th-cells (white histograms,
reference condition) and of allogenic Th-cells cocultured with eﬀector Th-cells when no α-IL-10 was added (no α-IL-10), α-IL-10 during
DC-na¨ ıve T-cell (α-IL-10 DC-T) coculture or α-IL-10 during eﬀector T-cell and allogenic T-cell (α-IL-10 T-T) coculture (gray histograms).
(b) Bar graphs represent the mean inhibition of ﬂuorescence intensity of allogenic Th-cells for the indicated conditions in triplicate. The
proliferation of allogenic Th-cells cocultured with eﬀector Th-cells induced by MF-matured DC is regarded as 100% (reference condition).
For transwell experiments, 2 × 106 PKH-labeled test cells were put in the upper compartment of a 24-well plate transwell system. Mean
percentages with standard error of mean are given; ∗∗indicates P<0.01 using the χ2-test for comparing percentages with the reference
condition (α-IL-10 DC-T and transwell, resp.).
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Figure 5: Immature DC primed with MF/L. lactis and increasing
amounts of recombinant human IL-10 (0, 0.5, 5 and 50ng/mL).
Bar graphs represent the mean inhibition of ﬂuorescence intensity
of allogenic Th-cells for the indicated conditions in duplo. The
proliferation of allogenic Th-cells cocultured with eﬀector Th-
cells derived from MF-matured DC is regarded as 100% (reference
condition). Mean percentages with standard error of mean are
given; ∗indicates P<0.05 and ∗∗indicates P<0.01 using the χ2-
test for comparing percentages with the reference condition (MF).
and 700pg/mL IL-10, respectively, (P<0.01, compared
to L. lactis, Figure 3(b)). The production of IFN-γ was
not signiﬁcantly diﬀerent between the groups (Figure 3(b)).
Finally, the addition of neutralizing IL-10 antibodies during
maturation of immature DC with L. lactisIL-10 signiﬁcantly
reversed the production of IL-10 by mature DC and eﬀector
Th-cells (P<0.01, compared to isotype control, Figures 3(a)
and 3(b)).
3.4. IL-10 Is Important for the Induction But Not for the
Function of Suppressor Th-Cells. Neutralizing IL-10 during
coculture of L. lactisIL-10 -matured DC and na¨ ıve Th-cells
completely abrogated the suppressive eﬀect of eﬀector Th-
cells on allogenic Th-cell proliferation (Figure 4(a)). How-
ever, neutralizing IL-10 during coculture of L. lactisIL-10 -
derived suppressor Th-cells and allogenic Th-cells did not
aﬀect the suppressive eﬀect on allogenic Th-cell proliferation
(P<0.01, compared to MF, Figure 4(b)). Also, neutralizing
TGF-β or CTLA-4 costimulation did not aﬀect the suppres-
sive eﬀect of L. lactisIL-10 -derived suppressor Th-cells on
allogenic Th-cells proliferation (P<0.01, compared to MF,
Figure 4(b)). Finally, the suppression of L. lactisIL-10 -derived
suppressor Th-cells on allogenic Th-cell proliferation was
completely abrogated by physical separation of suppressor
and allogenic Th-cells (Figure 4(b)).
3.5. Eﬃcient Delivery of Bacterial-Derived IL-10 to DC. An
amount of 105 cfu of L. lactisIL-10 produced 85pg/mL of IL-
10 in the absence of DC (data not shown). After 4 hours,
supernatants from DC cultured with viable L. lactisIL-106 Gastroenterology Research and Practice
and MF contained 130pg/mL (data not shown). Increas-
ing amount of recombinant human IL-10 (500pg/mL,
5000pg/mL, and 50.000pg/mL) during DC cultures with
viableL.lactisandMFincreasedthesuppressiveeﬀectofDC-
derived eﬀector Th-cells on allogenic Th-cell proliferation
to 67.5% (P<0.05, compared to MF), 46.5% (P<0.01,
compared to MF), and 48.5% (P<0.01, compared to MF),
respectively, (Figure 5).
4. Discussion
The eﬀective ability of DC to initiate diﬀerent types of Th-
cell responses makes this cell type an important target for
innovative strategies requiring either polarized immunity
(i.e., in vaccination or cancer) or tolerance (i.e., in chronic
inﬂammatory, autoimmune, or allergic diseases) [16]. The
immunoregulatory cytokine IL-10 plays a central role in the
induction and maintenance of mucosal tolerance through
the induction of regulatory DC [1]. However, IL-10 treat-
ment in humans with colitis is disappointing due to low
mucosal availability and proinﬂammatory eﬀects at higher
doses of IL-10 [7]. We hypothesized that L. lactisIL-10 is able
to modulate DC to become regulatory DC which in turn
induce suppressor T cells. To this aim, we cultured viable L.
lactisandL.lactisIL-10 withDCandassessedtheeﬀectofDC-
derived eﬀector Th-cells on allogenic Th-cell proliferation
in the absence of DC and bacteria. We observed that L.
lactis can imprint a regulatory DC phenotype which is even
morepronouncedbysecretionofIL-10.Theﬁnalsuppressive
eﬀect on Th-cell proliferation is probably in part due to
the intrinsic immunomodulatory eﬀect of L. lactis and in
part due to the presence of IL-10 during DC maturation. L.
lactis has much homology with several probiotic organisms
that are known to induce regulatory immune responses [15,
17, 18]. We had to culture L. lactisIL-10 (temporarily) alive
to allow IL-10 production and secretion. Hence, secreted
bacterial factors could also have modulated the maturation
process, phenotype, and suppressor function of DC. The
immunomodulatory eﬀect of IL-10 during priming of DC
in our model is in accordance with the ﬁndings of other
groups[19,20].Interestingly,lowlevelsofIL-10producedby
L. lactisIL-10 during DC maturation are suﬃcient to induce
regulatory DC. L. lactisIL-10 produced around 130pg/mL
IL-10 before antibiotics were added, and we needed up to
5000pg/mL of rh-IL-10 to produce comparable suppressive
eﬀects. Thus, approximately 40 times more IL-10 during
DC priming was needed to induce suppressor Th-cells,
suggesting that spatially restricted bacterial IL10 is more
eﬃcient than soluble IL-10 for the induction of regulatory
DC. It would be interesting to establish if this phenomenon
is also occurring in vivo and if other factors like bacterial
translocationacrosstheepitheliumandphysicalcontactwith
DC in the lamina propria and/or mesenteric lymph node are
necessary for inducing these suppressor immune responses
[21].
The induction of regulatory DC by L. lactisIL-10 was
characterized by full maturation, high production of IL-10,
and low production of IL-12p70 and IL-6. Moreover, IL-10
is required for the induction of suppressor Th-cells by DC
but not for the suppressive function of suppressor Th-cells
during coculture with allogenic Th-cells. The function of
IL-10 production by suppressor Th-cells cannot be deduced
from our experiments, but it might be important for the per-
sistence of regulatory immune responses through feedback
on newly recruited immature DC in the periphery in vivo
[22]. Unfortunately, we were not able to identify the driving
factor behind the suppressor eﬀect of Th-cell induced by L.
lactisIL-10 during T-T cell interaction. Both IL-10 and TGF-
βare not involved in the suppressive eﬀect of eﬀector Th-
cells on na¨ ıve T-cell proliferation. The transwell experiment
suggests that contact-dependent factors are important, but
CTLA-4 was ruled out by using a blocking antibody. Hence,
other contact-dependent factors like ICAM-3 and GITR
might be important in these eﬀector Th-cells induced by L.
lactisIL-10 [15,23].Itisanattractiveideatosuggestthatfoxp3
might play an important role in the induction of suppressor
Th-cells by L. lactisIL-10 -matured DC, but we have not yet
been able to prove such a relationship [24].
In conclusion, our data indicate that the observed anti-
inﬂammatory eﬀect of L. lactisIL-10 is mediated through
modulation of DC function. The utilization of L. lactis
for delivery of proteins has several advantages including
increased mucosal availability, ease of administration, lower
therapeutic doses, and cost eﬀectiveness. This strategy might
be applicable in the treatment of inﬂammatory and infec-
tious diseases [13, 25, 26].
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